We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 314

Tesla’s patent pledge: is it enough?

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 23 2014

Free use of patented technology? Caveat emptor. In a June 12, 2014 blog post titled, "All Our Patent Are Belong To You", Elon Musk, co-founder and

Antibody patent found valid and infringed

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 27 2014

The Court recently decided a patent infringement case dealing with antibodies. The claims at issue in AbbVie’s patent relate to the use of a human

Doctrine of bona fide purchaser for value without notice applies to patent rights

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 6 2012

This case involves a dispute over who owned certain patent rights

Reply affidavits allowed when new documents introduced in responding evidence

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 9 2014

In this case, there is a partial reversal of evidence. Apotex brought a motion for leave to file reply evidence. Allergan did not oppose parts of the

The hare or the tortoise? Options for speeding up patent prosecution in Canada

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 28 2013

Timelines for patent prosecution in Canada can vary greatly depending on the technology area, backlogs in the Canadian Intellectual Property Office

Leave to amend Statement of Defence denied

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • April 18 2011

Shire brought a motion seeking leave to amend its Statement of Defence to add a new defence of infringement as well as a defence of failure to mitigate

Supreme Court of Canada denies leave to appeal

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 3 2011

The Supreme Court of Canada refused leave in Teva Canada Limited v. Sanofi-Aventis Canada Inc. and Sanofi-Aventis Deutschland GmbH (Case No.34325

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 10 2013

In November, the Supreme Court issued its decision in the sildenafil case, and, as part of its order, found the patent to be invalid. As this case was

Janssen-Ortho v. Apotex

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 20 2010

This proceeding has had a complex history

Practice notice: Experimental testing

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 5 2014

The Federal Court has provided a new Notice to the Profession stating that in an action for infringement or validity of a patent, when a party